loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: DSSTox_CID_3333

    Client Email Product
    Menu

    DSSTox_CID_3333

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 6,379Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 20762 / DOSAGE - SPRAY, METERED;NASAL - 0.05MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    MOMETASONE FUROATE MONOHYDRATE(UNII: MTW0WEG809)
    (Mometasone - UNII:8HR4QJ6DW8)     		Mometasone50ug

    Inactive Ingredients

    Ingredient Name
    A-S Medication Solutions
    Merck Sharp & Dohme Corp.
    REMEDYREPACK INC.
    Sandoz Inc.
    benzalkonium chloride(F5UM2KM3W7)
    CARBOXYMETHYLCELLULOSE SODIUM(K679OBS311)   
    carboxymethylcellulose sodium, unspecified form(K679OBS311) 
    CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)   
    citric acid monohydrate(2968PHW8QP)
    glycerin(PDC6A3C0OX)
    microcrystalline cellulose(OP1R32D61U) 
    polysorbate 80(6OZP39ZG8H)
    SODIUM CITRATE(1Q73Q2JULR)   
    sodium citrate, unspecified form(1Q73Q2JULR)